Combined with transport assays and structural comparisons, our results ultimately define the Na+ and Cl− binding sites of NCC; provide clues for ion selectivity, coupling, and translocation; and promote further drug development for hypertension and Gitelman syndrome targeting on NCC. The gene discussed is SLC12A3; the disease is Hypertension.